Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study-Reference-Cited by-同舟云学术

Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study

Published:2020 Issue:5 Volume:5 Page:e000864
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Alanen Virve,Iivanainen Sanna,Arffman Martti,Koivunen Jussi Pekka^ORCID

Funder

Finnish Cancer Society

Oulun Yliopisto

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa survival evaluation in lung cancer);Thatcher;The Lancet,2005

2. First-Line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer;Greenhalgh;Cochrane Database of Systematic Reviews,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study;Acta Oncologica;2023-11-07

2. Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial;Cancer Medicine;2023-06-03

3. Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs;Scientific Reports;2023-05-23

4. Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study;BMC Cancer;2023-02-13

5. Intestinal Performance upon Broiler Chickens fed with or without Epidermal Growth Factor;2022-08-29